kabutan

Pharma Foods, Aug-Apr (Cumulative 3Q) Ordinary Profit Turns to Loss, Feb-Apr Ordinary Profit Turns to Loss

Tue Jun 10, 2025 1:30 pm JST Earnings

2929 Pharma Foods International Co., Ltd. 【J-GAAP】

Earnings Report

Pharma Foods International Co., Ltd. <2929> [TSE Prime] announced its financial results in the afternoon session on June 10th (13:30). The consolidated ordinary profit/loss for the cumulative third quarter of the fiscal year ending July 2025 (August 2024 to April 2025) turned into a loss of 0.23 billion yen (compared to a profit of 3.22 billion yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the May to July period (4Q) is expected to grow 24.9% from the same period last year, reaching 2.53 billion yen.

In the most recent three-month period, from February to April (3Q), the consolidated ordinary profit/loss turned to a loss of 0.87 billion yen (compared to a profit of 1.68 billion yen in the same period last year). The operating profit/loss margin drastically worsened from 11.2% in the same period last year to -5.0%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Aug - Apr, 2022 52,533 1,634 1,582 1,068 37.0 44.7 Jun 5, 2023 J-GAAP
Aug - Apr, 2023 47,171 3,266 3,223 1,856 65.0 61.4 Jun 10, 2024 J-GAAP
Aug - Apr, 2024 46,817 -217 -231 -1,123 -39.2 ー Jun 10, 2025 J-GAAP
YoY -0.8% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb - Jul, 2024 30,495 3,578 3,707 2,437 85.7 15 Sep 12, 2024 J-GAAP
Feb - Jul, 2025 Guidance 35,143 1,377 1,655 1,371 47.5 12.50 Mar 12, 2025 J-GAAP
YoY +15.2% -61.5% -55.4% -43.7% -44.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2023 68,572 3,610 3,540 3,081 106.7 22 Sep 11, 2023 J-GAAP
Jul, 2024 62,147 5,113 5,249 3,205 112.7 25 Sep 12, 2024 J-GAAP
Jul, 2025 Guidance 65,000 2,000 2,300 1,600 55.4 25 Sep 12, 2024 J-GAAP
YoY +4.6% -60.9% -56.2% -50.1% -50.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Feb - Apr, 2024 15,519 1,731 1,681 1,088 38.1 11.2 Jun 10, 2024 J-GAAP
May - Jul, 2024 14,976 1,847 2,026 1,349 47.4 12.3 Sep 12, 2024 J-GAAP
Aug - Oct, 2024 14,596 882 888 360 12.9 6.0 Dec 11, 2024 J-GAAP
Nov - Jan, 2024 15,261 -259 -243 -131 -4.6 -1.7 Mar 12, 2025 J-GAAP
Feb - Apr, 2025 16,960 -840 -876 -1,352 -47.2 -5.0 Jun 10, 2025 J-GAAP
YoY +9.3% － － － －

Related Articles